An individual patient meta-analysis assessed the associations between change in albuminuria and acute changes in the glomerular filtration rate in randomized controlled trials of chronic kidney disease progression.

Authors

Lesley A Inker, Hiddo J L Heerspink, Hocine Tighiouart, Shiyuan Miao, Juhi Chaudhari, Lucia Del Vecchio, Jürgen Floege, Thierry Hannedouche, Enyu Imai, Tazeen H Jafar, Julia B Lewis, Philip K T Li, Francesco Locatelli, Bart D Maes, Brendon L Neuen, Ronald D Perrone, Francesco P Schena, Robert D Toto, Christoph Wanner, Tom Greene

Published in

Kidney international. Sep 30, 2026. Epub Sep 30, 2026.

Abstract

Early changes in albuminuria and glomerular filtration rate (GFR) have been proposed as markers of treatment efficacy for individual patients. Here, we evaluated the relationship between changes in GFR and in albuminuria in the immediate period following initiation of medication across trials and within individual patients.
In 49 randomized controlled trials encompassing 66,449 eligible participants, we estimated early changes in GFR from baseline to three months and in albuminuria from baseline to six months. We first used Bayesian mixed-effects meta-regression to relate treatment effects on early GFR change (acute effects) with treatment effects on albuminuria across trials. Second, we examined associations between an individual's change in GFR and albuminuria using adjusted linear regression in both the treatment and control arms.
There was no evidence of association between mean treatment effects on GFR and albuminuria across studies [meta-regression slope 0.00 (95% Bayesian credible intervals, BCI -0.08, 0.09), R² 0.03 (95% BCI 0.03, 0.27)]. For individual patients, similar magnitude of associations between changes in albuminuria and in GFR were observed in both arms: for each standard deviation greater decline in GFR, the geometric mean albumin/creatinine ratio declined by 8.0% (7.1%, 8.9%) in participants in the treatment arm and by 6.6% (5.6%, 7.6%) in those in the control arm. The effect was seen in each of the intervention classes except for the immunosuppressive studies, where this association was not observed within either the intervention or control arms.
The similar associations between changes in GFR and albuminuria for individual patients in both treatment and control arms and no association between the treatment effects on GFR and on albuminuria at the trial level. This suggests that early changes in GFR and albuminuria may be more likely related to natural history of the disease or other factors, rather than the effect of treatments.

PMID:
42815853
Bibliographic data and abstract were imported from PubMed on 01 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.